Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-11-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.1478 |
_version_ | 1797448565114535936 |
---|---|
author | Junya Yan Long Deng Jiayi Yu Xiaowen Wu Shaoyu Wang Shundong Cang |
author_facet | Junya Yan Long Deng Jiayi Yu Xiaowen Wu Shaoyu Wang Shundong Cang |
author_sort | Junya Yan |
collection | DOAJ |
first_indexed | 2024-03-09T14:12:17Z |
format | Article |
id | doaj.art-e4b0a21424cf4e7bafd76a6b75a1b878 |
institution | Directory Open Access Journal |
issn | 2001-1326 |
language | English |
last_indexed | 2024-03-09T14:12:17Z |
publishDate | 2023-11-01 |
publisher | Wiley |
record_format | Article |
series | Clinical and Translational Medicine |
spelling | doaj.art-e4b0a21424cf4e7bafd76a6b75a1b8782023-11-29T06:48:31ZengWileyClinical and Translational Medicine2001-13262023-11-011311n/an/a10.1002/ctm2.1478Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanomaJunya Yan0Long Deng1Jiayi Yu2Xiaowen Wu3Shaoyu Wang4Shundong Cang5Department of OncologyHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's HospitalZhengzhou ChinaWestern Medical Branch of the Chinese PLA General Hospital Beijing ChinaDepartment of Radiation Oncology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing ChinaDepartment of Renal Cancer and Melanoma Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing ChinaHenan Key Laboratory of Imaging and Intelligent Processing PLA Strategic Support Force Information Engineering University Zhengzhou ChinaDepartment of OncologyHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's HospitalZhengzhou Chinahttps://doi.org/10.1002/ctm2.1478 |
spellingShingle | Junya Yan Long Deng Jiayi Yu Xiaowen Wu Shaoyu Wang Shundong Cang Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma Clinical and Translational Medicine |
title | Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma |
title_full | Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma |
title_fullStr | Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma |
title_full_unstemmed | Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma |
title_short | Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma |
title_sort | multi cohort analysis identifies somatic ntrk mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma |
url | https://doi.org/10.1002/ctm2.1478 |
work_keys_str_mv | AT junyayan multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma AT longdeng multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma AT jiayiyu multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma AT xiaowenwu multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma AT shaoyuwang multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma AT shundongcang multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma |